Pinky Sharma, V. Jhawat, Jatinder Singh, Rohit Dutt
{"title":"印度新晋科学家对新兴癌症疗法及其法规的了解和认识:一项调查","authors":"Pinky Sharma, V. Jhawat, Jatinder Singh, Rohit Dutt","doi":"10.2174/0115733947268695231116100736","DOIUrl":null,"url":null,"abstract":"\n\nAcademic clinical research is considered the most important for cancer research\nbecause it frequently tests novel drug combinations, investigates rarer diseases, and lowers the\nrisk for future commercial investments. However, due to the potential risks to the cancer patient, clinical\nresearch is governed by strict regulations. In high-income countries, comprehensive cancer centers\n(CCCs) have been established to align academic clinical cancer research with the regulatory\nframework. In comparison, academic clinical cancer research is considered ineffective in low-income\ncountries.\n\n\n\nA cross-sectional, online survey was conducted to evaluate the knowledge of Indian health\nscience students regarding cutting-edge cancer therapeutics and their underlying regulatory requirements.\n\n\n\nThe survey found that 163 out of the 265 respondents were aware of the challenges of developing\nsafe and effective anticancer therapeutics. 43 respondents found no challenges, while 59\nrespondents were unaware of any. Out of 163, 44 respondents identified technical challenges, 31\nidentified regulatory issues, and 88 identified both challenges in developing novel anticancer therapeutics.\nInterestingly, only 83 students out of 265, study cancer therapy regulations in their curriculum.\nThis clearly indicates that most of India's health science students have a significant lack of understanding\nabout the regulations for new cancer treatments.\n\n\n\nAcademic clinical cancer research in India is just recognized as a prerequisite for degree\ncompletion due to a lack of regulatory foundation. An emphasis should be placed on restructuring the\ncoursework offered to health science students to improve their ability to translate theoretical cancer\nresearch to real-world clinical care.\n","PeriodicalId":503819,"journal":{"name":"Current Cancer Therapy Reviews","volume":"31 16","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Knowledge and Awareness of Emerging Cancer Therapies and their Regulations among Budding Scientists in India: A Survey\",\"authors\":\"Pinky Sharma, V. Jhawat, Jatinder Singh, Rohit Dutt\",\"doi\":\"10.2174/0115733947268695231116100736\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n\\nAcademic clinical research is considered the most important for cancer research\\nbecause it frequently tests novel drug combinations, investigates rarer diseases, and lowers the\\nrisk for future commercial investments. However, due to the potential risks to the cancer patient, clinical\\nresearch is governed by strict regulations. In high-income countries, comprehensive cancer centers\\n(CCCs) have been established to align academic clinical cancer research with the regulatory\\nframework. In comparison, academic clinical cancer research is considered ineffective in low-income\\ncountries.\\n\\n\\n\\nA cross-sectional, online survey was conducted to evaluate the knowledge of Indian health\\nscience students regarding cutting-edge cancer therapeutics and their underlying regulatory requirements.\\n\\n\\n\\nThe survey found that 163 out of the 265 respondents were aware of the challenges of developing\\nsafe and effective anticancer therapeutics. 43 respondents found no challenges, while 59\\nrespondents were unaware of any. Out of 163, 44 respondents identified technical challenges, 31\\nidentified regulatory issues, and 88 identified both challenges in developing novel anticancer therapeutics.\\nInterestingly, only 83 students out of 265, study cancer therapy regulations in their curriculum.\\nThis clearly indicates that most of India's health science students have a significant lack of understanding\\nabout the regulations for new cancer treatments.\\n\\n\\n\\nAcademic clinical cancer research in India is just recognized as a prerequisite for degree\\ncompletion due to a lack of regulatory foundation. An emphasis should be placed on restructuring the\\ncoursework offered to health science students to improve their ability to translate theoretical cancer\\nresearch to real-world clinical care.\\n\",\"PeriodicalId\":503819,\"journal\":{\"name\":\"Current Cancer Therapy Reviews\",\"volume\":\"31 16\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-01-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Current Cancer Therapy Reviews\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2174/0115733947268695231116100736\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Cancer Therapy Reviews","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/0115733947268695231116100736","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Knowledge and Awareness of Emerging Cancer Therapies and their Regulations among Budding Scientists in India: A Survey
Academic clinical research is considered the most important for cancer research
because it frequently tests novel drug combinations, investigates rarer diseases, and lowers the
risk for future commercial investments. However, due to the potential risks to the cancer patient, clinical
research is governed by strict regulations. In high-income countries, comprehensive cancer centers
(CCCs) have been established to align academic clinical cancer research with the regulatory
framework. In comparison, academic clinical cancer research is considered ineffective in low-income
countries.
A cross-sectional, online survey was conducted to evaluate the knowledge of Indian health
science students regarding cutting-edge cancer therapeutics and their underlying regulatory requirements.
The survey found that 163 out of the 265 respondents were aware of the challenges of developing
safe and effective anticancer therapeutics. 43 respondents found no challenges, while 59
respondents were unaware of any. Out of 163, 44 respondents identified technical challenges, 31
identified regulatory issues, and 88 identified both challenges in developing novel anticancer therapeutics.
Interestingly, only 83 students out of 265, study cancer therapy regulations in their curriculum.
This clearly indicates that most of India's health science students have a significant lack of understanding
about the regulations for new cancer treatments.
Academic clinical cancer research in India is just recognized as a prerequisite for degree
completion due to a lack of regulatory foundation. An emphasis should be placed on restructuring the
coursework offered to health science students to improve their ability to translate theoretical cancer
research to real-world clinical care.